SKF AB Series A (0NWW)
London Exchange · UK · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 270.00 |
|---|---|
| 52-week range | 205.00 – 281.00 |
| Return, 1 month / 3 months | +3.4% / +14.4% |
| Return, 1 year / 3 years | +13.9% / +51.9% |
| Trend | Uptrend |
| RSI (14) | 51 |
| Volatility (1 year) | 33.0% |
| Worst drawdown (1 year) | -18.9% |
| Average daily value traded | 0.01M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SKF AB is a Swedish industrial company that makes bearings, seals, lubrication systems and related mechanical components. It supplies rolling bearings and sealing solutions to manufacturers of machinery, vehicles and industrial equipment, and also serves maintenance and aftermarket customers through distributors. The company is based in Gothenburg, Sweden, and its products are used in applications ranging from electric motors and gearboxes to pumps, fans and production machinery around the world.
On this site SKF AB Series A appears as a stock on the London Exchange (UK), code 0NWW, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SKF AB Series A (0NWW) trades on the London Exchange in UK. It last closed at SEK 270.00 on 19 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,157 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.9% and over the last three months it rose 14.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.7% | ||
| From 52-week high | -3.9% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 14.4% | ||
| 6-month return | 7.1% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.9% | ||
| Liquidity | 15 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M SEK | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | +3.4% |
| 3 months | +14.4% |
| 6 months | +7.1% |
| 1 year | +13.9% |
| 3 years | +51.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 264.53 / 248.47 |
|---|---|
| Golden / death cross (60 days) | Golden, 47 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.75 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2025 | SEK 7.7500 |
| 27 Mar 2024 | SEK 7.5000 |
| 24 Mar 2023 | SEK 7.0000 |
| 25 Mar 2022 | SEK 7.0000 |
| 26 Mar 2021 | SEK 6.5000 |
| 27 Mar 2020 | SEK 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.